About Ayumi Pharmaceutical
Ayumi Pharmaceutical is a Healthcare company based in Tokyo (Japan) founded in 2015, and was acquired by GNI Group in June 2026. Specialty generic drugs for rheumatism and orthopedics are manufactured. Its chief executive, as recorded, is Kiyoaki Karasawa. Its website ayumi-pharma.com draws about 20 thousand monthly visits. Its focus areas include Traditional Pharmaceuticals, Generics and Therapeutic Areas. Its legal entity is Ayumi Pharmaceutical Corporation.
Company details
Ayumi Pharmaceutical was founded in 2015 in Tokyo, Japan, within the pharmaceutical sector. Generic products are manufactured, with operations centered on therapeutic areas including rheumatism and orthopedics. Focus is placed on specialty drugs for these fields, supporting healthcare needs in musculoskeletal conditions. The company is led from its base in Japan, contributing to the generics market.
- Headquarters Tokyo, Japan
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website ayumi-pharma.com
- Acquired by Blackstone (Mar 2019)
- Legal Name Ayumi Pharmaceutical Corporation
- InvestorsBlackstone
& 1 more
- Acquired by
Investors in Ayumi Pharmaceutical
Ayumi Pharmaceutical has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Blackstone and GNI Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Diversified investment management is provided across multiple asset classes. | 1985 | blackstone.com | New York, United States | |
Multinational company engaged in the research, development, & manufacturing of pharmaceutical drugs | 2001 | gnipharma.com | Chiba, Japan |
Investor details for Ayumi Pharmaceutical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Ayumi Pharmaceutical
1 people are tracked at Ayumi Pharmaceutical (1 in leadership).
| Name | Role | Group |
|---|---|---|
Kiyoaki Karasawa | CEO & President | Leadership |
Complete people profiles for Ayumi Pharmaceutical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Ayumi Pharmaceutical
3 dated milestones of Ayumi Pharmaceutical across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Ayumi Pharmaceutical is founded.
- Exit Acquired by Blackstone.
- Exit Acquired by GNI Group.
Web traffic of Ayumi Pharmaceutical
The website of Ayumi Pharmaceutical (ayumi-pharma.com) receives about 20.5K visits a month and ranks #1,074,661 among all websites worldwide, #1,329 in Biotechnology and Pharmaceuticals.
- Monthly visits20.5K
▼ 19.5% vs previous month
- Unique visitors16.3K
per month
- Global rank#1,074,661
among all websites
- Category rank#1,329
Health · Biotechnology and Pharmaceuticals
- Bounce rate62%
- Pages per visit2.0
- Average visit1 min 45 sec
- DevicesDesktop 24% · Mobile 76%
Websites whose visitors overlap most with Ayumi Pharmaceutical. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
otomoclinic.com | otomoclinic.com | 100% | #2,438,040 | – | |
biosimilar.jp | biosimilar.jp | 97% | #4,393,528 | – | |
chugai-ra.jp | chugai-ra.jp | 89% | #1,108,368 | – | |
| ono-pharma.com | 88% | 112.3K | #536,517 | View details | |
e-humira.jp | e-humira.jp | 88% | #2,994,998 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 31 similar websites and full traffic analytics for Ayumi Pharmaceutical
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 31 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ayumi Pharmaceutical
Complete news archive for Ayumi Pharmaceutical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ayumi Pharmaceutical
Ayumi Pharmaceutical was founded in 2015.
Ayumi Pharmaceutical is headquartered in Tokyo, Japan. It is registered at Tokyo, Tokyo, Japan.
Kiyoaki Karasawa is the CEO of Ayumi Pharmaceutical, as recorded in our data.
Ayumi Pharmaceutical was founded in 2015 in Tokyo, Japan, within the pharmaceutical sector. Generic products are manufactured, with operations centered on therapeutic areas including rheumatism and orthopedics. Focus is placed on specialty drugs for these fields, supporting healthcare needs in musculoskeletal conditions. The company is led from its base in Japan, contributing to the generics market.
Ayumi Pharmaceutical has 2 investors. Key investors include Blackstone, and GNI Group.
Ayumi Pharmaceutical operates through Ayumi Pharmaceutical Corporation.
Yes. Ayumi Pharmaceutical was acquired by Blackstone in March 2019.